ABSTRACT Introduction On 31 July 2023, the United States Department of Health and
Human Services announced the formation of the Office of Long COVID Research and …

Purpose Preliminary evidence suggests a potential effect of antiviral medication used during
the acute COVID-19 phase for preventing long-COVID. This review investigates if having …

Antiviral treatment reduces the severity and mortality of SARS-CoV-2 infection; however, its
effectiveness against long COVID-19 is unclear. This study aimed to evaluate the …

Background Few studies have directly compared the risk and magnitude of post-acute
sequelae following COVID-19 and influenza, and most of these studies were conducted …

Objectives This study aimed to determine the association of early use of oral antiviral drugs
(including nirmatrelvir-ritonavir and molnupiravir) with the risk of PCC and compare the …

Background The outcomes of older adult people acquiring SARS-CoV-2 reinfection was
unclear. This study aimed to compare the outcomes of older adult patients with COVID-19 …

Background Azvudine and nirmatrelvir/ritonavir are approved to treat mild-to-moderate
coronavirus disease 2019 (COVID-19) in adults with a high risk for progression to severe …

The COVID-19 pandemic has resulted in a growing number of patients experiencing
persistent symptoms and physiological changes after recovering from acute SARS-CoV-2 …

This study investigated the clinical effectiveness of nirmatrelvir plus ritonavir (NMV‐r) on
short‐term outcome and the risk of postacute sequelae of severe acute respiratory syndrome …

The aim of this study was to investigate the effects of administrating Remdesivir at the acute
COVID-19 phase on developing post-COVID symptoms in previously hospitalized COVID-19 …